2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Female Scientist Award
2022 - Research.com Best Scientist Award
Her scientific interests lie mostly in Internal medicine, Risk factor, Prospective cohort study, Relative risk and Myocardial infarction. The Internal medicine study combines topics in areas such as Endocrinology and Surgery. Her study in Endocrinology is interdisciplinary in nature, drawing from both Odds ratio and C-reactive protein.
Her Risk factor research incorporates themes from Epidemiology, Lower risk, Blood pressure, Proportional hazards model and Physical therapy. Her work deals with themes such as Cohort study, Environmental health, Gastroenterology, Hazard ratio and Confounding, which intersect with Prospective cohort study. As a member of one scientific family, she mostly works in the field of Myocardial infarction, focusing on Disease and, on occasion, Genetics and Genome-wide association study.
Julie E. Buring focuses on Internal medicine, Prospective cohort study, Endocrinology, Risk factor and Relative risk. Julie E. Buring combines subjects such as Surgery and Oncology with her study of Internal medicine. Her work in Surgery covers topics such as Myocardial infarction which are related to areas like Disease.
Her work in Prospective cohort study addresses issues such as Epidemiology, which are connected to fields such as Gerontology. Her study connects C-reactive protein and Endocrinology. Julie E. Buring interconnects Stroke, Blood pressure and Cardiology in the investigation of issues within Risk factor.
Her main research concerns Internal medicine, Vitamin D and neurology, Prospective cohort study, Gastroenterology and Disease. She combines topics linked to Oncology with her work on Internal medicine. Her Vitamin D and neurology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Type 2 diabetes, Placebo and Fatty acid.
Her Prospective cohort study study integrates concerns from other disciplines, such as Mortality rate, Epidemiology, Proportional hazards model and Cohort study. In Body mass index, she works on issues like Risk factor, which are connected to Incidence. The various areas that she examines in her Randomized controlled trial study include Stroke and Cancer.
Internal medicine, Prospective cohort study, Vitamin D and neurology, Gastroenterology and Randomized controlled trial are her primary areas of study. Her Internal medicine study typically links adjacent topics like Oncology. Her Prospective cohort study study also includes
Her Vitamin D and neurology study incorporates themes from Placebo and Mood. She works mostly in the field of Randomized controlled trial, limiting it down to topics relating to Fatty acid and, in certain cases, Systemic inflammation and Inflammation, as a part of the same area of interest. Her research integrates issues of Obesity, Proportional hazards model and Risk factor in her study of Body mass index.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
Paul M Ridker;Charles H Hennekens;Julie E Buring;Nader Rifai.
The New England Journal of Medicine (2000)
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Aruna D. Pradhan;JoAnn E. Manson;Nader Rifai;Julie E. Buring.
JAMA (2001)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
Paul M. Ridker;Nader Rifai;Lynda Rose;Julie E. Buring.
Obstetrical & Gynecological Survey (2003)
Epidemiology in Medicine
Charles H. Hennekens;Julie E. Buring;Sherry L. Mayrent.
(1987)
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Paul M Ridker;Julie E. Buring;Nancy R. Cook;Nader Rifai.
Circulation (2003)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Colin Baigent;Lisa Blackwell;Rory Collins.
The Lancet (2009)
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
C H Hennekens;J E Buring;J E Manson;M Stampfer.
The New England Journal of Medicine (1996)
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
Paul M Ridker;Nancy R. Cook;I-Min Lee;David Gordon.
The New England Journal of Medicine (2005)
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Paul M. Ridker;Julie E. Buring;Jessie Shih;Mathew Matias.
Circulation (1998)
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Paul M Ridker;Julie E. Buring;Nader Rifai;Nancy R. Cook.
JAMA (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Harvard Medical School
Brigham and Women's Hospital
Harvard University
Brigham and Women's Hospital
Brigham and Women's Hospital
Harvard Medical School
Charité - University Medicine Berlin
Harvard Medical School
University of Melbourne
Brigham and Women's Hospital
University of Michigan–Ann Arbor
University of Maryland, College Park
Rutgers, The State University of New Jersey
The University of Texas at Austin
University of Turin
Stanford University
Roosevelt University
University of Mississippi
Iowa State University
Northeast Normal University
University of Geneva
Novartis (United States)
Keio University
University of Barcelona
Mayo Clinic
University of Rochester